These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37941807)

  • 1. RuX: A Novel, Flexible, and Sensitive Mifepristone-Induced Transcriptional Regulation System.
    Meinzinger A; Zsigmond Á; Horváth P; Kellenberger A; Paréj K; Tallone T; Flachner B; Cserhalmi M; Lőrincz Z; Cseh S; Shmerling D
    Int J Cell Biol; 2023; 2023():7121512. PubMed ID: 37941807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New variants of inducible Cre recombinase: a novel mutant of Cre-PR fusion protein exhibits enhanced sensitivity and an expanded range of inducibility.
    Wunderlich FT; Wildner H; Rajewsky K; Edenhofer F
    Nucleic Acids Res; 2001 May; 29(10):E47. PubMed ID: 11353092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric Cre recombinase inducible by synthetic,but not by natural ligands of the glucocorticoid receptor.
    Brocard J; Feil R; Chambon P; Metzger D
    Nucleic Acids Res; 1998 Sep; 26(17):4086-90. PubMed ID: 9705523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactions.
    Kaczmarczyk SJ; Green JE
    Nucleic Acids Res; 2003 Aug; 31(15):e86. PubMed ID: 12888538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantity of partial agonist activity for antiglucocorticoids complexed with mutant glucocorticoid receptors is constant in two different transactivation assays but not predictable from steroid structure.
    Sarlis NJ; Bayly SF; Szapary D; Simons SS
    J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):89-102. PubMed ID: 10369406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
    Yu YA; Szalay AA
    Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations.
    Yasuda S; Aoyama S; Yoshimoto R; Li H; Watanabe D; Akiyama H; Yamamoto K; Fujiwara T; Najima Y; Doki N; Sakaida E; Edahiro Y; Imai M; Araki M; Komatsu N; Miura O; Kawamata N
    Int J Hematol; 2021 Oct; 114(4):424-440. PubMed ID: 34165774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator.
    Wang Y; Xu J; Pierson T; O'Malley BW; Tsai SY
    Gene Ther; 1997 May; 4(5):432-41. PubMed ID: 9274720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer-binding protein beta is an accessory factor for the glucocorticoid response from the cAMP response element in the rat phosphoenolpyruvate carboxykinase gene promoter.
    Yamada K; Duong DT; Scott DK; Wang JC; Granner DK
    J Biol Chem; 1999 Feb; 274(9):5880-7. PubMed ID: 10026211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated gene insertion by steroid-induced PhiC31 integrase.
    Sharma N; Moldt B; Dalsgaard T; Jensen TG; Mikkelsen JG
    Nucleic Acids Res; 2008 Jun; 36(11):e67. PubMed ID: 18499713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated regulable target gene expression in vivo.
    Burcin MM; Schiedner G; Kochanek S; Tsai SY; O'Malley BW
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):355-60. PubMed ID: 9892637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms.
    Burnstein KL; Jewell CM; Sar M; Cidlowski JA
    Mol Endocrinol; 1994 Dec; 8(12):1764-73. PubMed ID: 7708063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
    Schuetz JD; Schuetz EG; Thottassery JV; Guzelian PS; Strom S; Sun D
    Mol Pharmacol; 1996 Jan; 49(1):63-72. PubMed ID: 8569713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins.
    Braselmann S; Graninger P; Busslinger M
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1657-61. PubMed ID: 8446579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLP and Cre recombinase function in Xenopus embryos.
    Werdien D; Peiler G; Ryffel GU
    Nucleic Acids Res; 2001 Jun; 29(11):E53-3. PubMed ID: 11376165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone-inducible LexPR system to drive and control gene expression in transgenic zebrafish.
    Emelyanov A; Parinov S
    Dev Biol; 2008 Aug; 320(1):113-21. PubMed ID: 18544450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function.
    Webster NJ; Green S; Jin JR; Chambon P
    Cell; 1988 Jul; 54(2):199-207. PubMed ID: 3390864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic recombination as a reporter for screening steroid receptor agonists and antagonists.
    Dias JM; Go NF; Hart CP; Mattheakis LC
    Anal Biochem; 1998 Apr; 258(1):96-102. PubMed ID: 9527854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional and posttranslational regulation of Cre recombinase by RU486 as the basis for an enhanced inducible expression system.
    Kyrkanides S; Miller Jn; Bowers WJ; Federoff HJ
    Mol Ther; 2003 Nov; 8(5):790-5. PubMed ID: 14599812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
    Vergis N; Phillips R; Cornelius V; Katsarou A; Youngstein T; Cook L; Willicombe M; Pilay C; Shturova T; Almonte M; Charania A; Turner R; Kon OM; Cooke G; Thursz M; Cherlin S; Wason J; Milojkovic D; Innes AJ; Cooper N
    Trials; 2021 Apr; 22(1):270. PubMed ID: 33845867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.